To date, there is little guidance how IP-related vexatious litigation should be assessed under Art. 102 TFEU. But a suitable framework can be developed to determine how such practices would be treated if adopted. That framework can be based on the limited case law existing in Europe on that topic, on the extensive enquiry recently carried out by the European Commission in the pharmaceutical sector and on a comparison with US case law
Towards an EU doctrine of anticompetitive IP-related litigation
Vezzoso, Simonetta
2012-01-01
Abstract
To date, there is little guidance how IP-related vexatious litigation should be assessed under Art. 102 TFEU. But a suitable framework can be developed to determine how such practices would be treated if adopted. That framework can be based on the limited case law existing in Europe on that topic, on the extensive enquiry recently carried out by the European Commission in the pharmaceutical sector and on a comparison with US case lawFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Vezzoso_Towards an EU Doctrine of Anticompetitive.pdf
Solo gestori archivio
Tipologia:
Versione editoriale (Publisher’s layout)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
162.45 kB
Formato
Adobe PDF
|
162.45 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione
